Skip to main content

Find Clinical Trials

Home
Conditions
Dyslipidemias

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

1,810 public trials 143 recruiting studies

Refine in advanced search Browse all conditions

Dyslipidemias trial results

Completed

Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)

NCT00166504

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED)

NCT00654628

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

Effects of Replacing Energy From Solid Fats and Added Sugars (SoFAS) With Avocado

NCT04990817

Conditions: Dyslipidemias, Elevated Triglycerides, Hyperlipidemias, +4 more
Locations: Great Lakes Clinical Trials Chicago, Illinois, United States

I-CTSI Clinical Research Center Indianapolis, Indiana, United States

View Trial Details

Completed

Coadministration of Ezetimibe and Simvastatin in Patients With Primary Hypercholesterolemia (P05457)

NCT00653523

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)

NCT05742841

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456)

NCT00654095

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)

NCT02741245

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)

NCT02460159

Conditions: Dyslipidemias, Heterozygous Familial Hypercholesterolemia, Hypercholesterolemia, +4 more
Locations: Not specified

View Trial Details

Completed

To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)

NCT00271817

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)

NCT03768427

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: The First Affiliated Hospital of Baotou Medical College ( Site 0025) Baotou, Anhui, China

Beijing Anzhen Hospital. Capital Medical University ( Site 0001) Beijing, Anhui, China

Aero Space center hospital ( Site 0003) Beijing, Beijing Municipality, China

Beijing Friendship Hospital ( Site 0005) Beijing, Beijing Municipality, China

View all 30 locations

View Trial Details